Pharmaceutical Technology's In the Lab eNewsletter
The TSQ Fortis Triple Quadrupole Mass Spectrometer from Thermo Fisher Scientific offers fast, robust liquid chromatography-mass spectrometry (LC-MS/MS) analysis for clinical research laboratories.
The Thermo Scientific TSQ Fortis Triple Quadrupole Mass Spectrometer allows clinical research laboratory scientists who face challenges in developing reproducible and reliable methods for the quantitation of analytes in biological matrices to achieve higher productivity while meeting laboratory demands.
The mass spectrometer is suited for applications that demand speed, robustness, and sensitivity for the quantitation of compounds in biological matrices by users with varying levels of expertise.
Features include:
The instrument’s platform is built on a foundation of shared hardware and software components and can be paired with a range of high-performance Thermo Scientific liquid chromatography systems. This pairing capability enables users to go from single-sample-based experiments to validation to routine high-volume screening and quantification, the company reports.
Source: Thermo Fisher Scientific
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.